If we were to really put rose tinted glasses on.. tell me what's the reason we won't be worth 20b+ in the next 2-3 years??20% market pen x 8 refills = 11.52B USD... Do your future valuations on that number.We are also completely non-invasive, w/ low side effects.I've said previously, PME does sub $100m revenue annually..If we MATCH Japans 300,000 patients x 8 refills = 1.02B USD annually. If the sales force completely knock it out of the park over the next 2 quarters - we will have seriously massive leverage for t/o's.Thats when management have free reign to give future valuations using blue sky numbers..
AII NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors
(20min delay)